510(K) CLEARANCES 84 ▲14RECALLS POSTED 39 ▲27CLASS I 6 ▲2PMA DECISIONS 47 ▲11WEEK ENDING / FDA DATA AS OF
Medical Device
ManufacturingTHE TRADE PAPER OF THE FACTORY FLOOR
SUBSCRIBE / SIGN IN
K132234Substantially Equivalent

Liaison(r) Toxo Igg II, Liaison(r) Control Toxo Igg II

Diasorin Inc., Stillwater MN / Traditional, Substantially Equivalent
FDA source (opens on fda.gov)510(k) summary (opens on fda.gov)

K132234 is the FDA 510(k) clearance record for LIAISON(R) TOXO IGG II, LIAISON(R) CONTROL TOXO IGG II, a class II device, cleared for DiaSorin, Inc. on under FDA product code LGD (Enzyme Linked Immunoabsorbent Assay, Toxoplasma Gondii). FDA records list 74 510(k) clearances for DiaSorin, Inc., from to . As of , FDA records show no recalls naming K132234.

Clearance record

Decision date
Received
(41 days to decision)
Product code
LGD Enzyme Linked Immunoabsorbent Assay, Toxoplasma Gondii
Regulation
21 CFR 866.3780
Device class
Class II
Review panel
Microbiology
Applicant
DiaSorin, Inc. 1951 Northwestern Ave., Stillwater MN
510(k) summary
Summary PDF
Third party review
No

Clearances, product code LGD

Trailing 12 months

FDA records hold no clearances under product code LGD in the trailing twelve months.

FDA records show no clearances under product code LGD in the twelve months to October 2026.
Show the numbers
Monthly 510(k) clearances under FDA product code LGD, trailing twelve months
MonthClearances
November 20250
December 20250
January 20260
February 20260
March 20260
April 20260
May 20260
June 20260
July 20260
August 20260
September 20260
October 20260